Nutraceutical effects of fucoxanthin for obesity and diabetes therapy: A review

Journal of Oleo Science

Volumn 64, Issue 2, 2015, Pages 125-132

  Maeda, Hayato ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Carotenoid; Diabetes; Fucoxanthin; Obesity; UCP1 (uncoupling protein 1)

Indexed keywords

ALGAE; ENZYME INHIBITION; FATTY ACIDS; GLUCOSE; HEALTH RISKS; INSULIN; MEDICAL PROBLEMS; PIGMENTS; PROTEINS;

CARDIO-VASCULAR DISEASE; CAROTENOID; FUCOXANTHIN; GLUCOSE TRANSPORTER 4; MITOCHONDRIAL PROTEIN; OBESITY; UNCOUPLING PROTEIN-1; WHITE ADIPOSE TISSUES;

NUTRITION;

ADIPOCYTOKINE; DRUG THERAPY; FATTY ACID; FUCOXANTHIN; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORTER 4; ION CHANNEL; MITOCHONDRIAL PROTEIN; MITOCHONDRIAL UNCOUPLING PROTEIN; PHARMACOLOGY; XANTHOPHYLL;

ANIMAL; BROWN ALGA; CHEMISTRY; DIABETES MELLITUS; DISEASE MODEL; DRUG EFFECTS; DRUG THERAPY; ENERGY METABOLISM; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; ISOLATION AND PURIFICATION; METABOLIC SYNDROME X; METABOLISM; MOUSE; OBESITY; OXIDATION REDUCTION REACTION; PHYSIOLOGY; PHYTOTHERAPY; PREVENTION; SKELETAL MUSCLE; WHITE ADIPOSE TISSUE;

ADIPOKINES; ADIPOSE TISSUE, WHITE; ANIMALS; BLOOD GLUCOSE; CHEMISTRY; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; DRUG EFFECTS; DRUG THERAPY; ENERGY METABOLISM; FATTY ACIDS; GENE EXPRESSION; GENE EXPRESSION REGULATION, PLANT; GENETICS; GLUCOSE TRANSPORTER TYPE 4; HUMANS; INSULIN RESISTANCE; ION CHANNELS; ISOLATION AND PURIFICATION; METABOLIC SYNDROME X; METABOLISM; MICE; MITOCHONDRIAL PROTEINS; MUSCLE, SKELETAL; OBESITY; OXIDATION-REDUCTION; PHAEOPHYTA; PHARMACOLOGY; PHYSIOLOGY; PHYTOTHERAPY; PREVENTION AND CONTROL; THERAPEUTIC USE; XANTHOPHYLLS;

EID: 84964211780     PISSN: 13458957     EISSN: 13473352     Source Type: Journal    
DOI: 10.5650/jos.ess14226     Document Type: Review

References (38)

1. Lew, E. A.; Garfinkel, L. Variations in mortality by weight among 750,000 men and women. J. Chronic. Dis. 32, 563-576 1979.
2. Olefsky, J. M.; Revers, R. R.; Prince, M.; Henry, R. R.; Garvey, W. T.; Scarlett, J. A.; Kolterman, O. G. Insulin resistance in non-insulin dependent （type II）and insulin dependent（type I）diabetes mellitus. Adv. Exp. Med. Biol. 189, 176-205 1985.
3. Matsuno, T. Aquatic animal carotenoids. Fisheries Science 67, 771-783 2001.
4. Sachindra, N. M.; Sato, E.; Maeda, H.; Hosokawa, M.; Niwano, Y.; Kohno, M.; Miyashita, K. Radical scavenging and singlet oxygen quenching activity of marine carotenoid fucoxanthin and its metabolites. J. Agric. Food. Chem. 55, 8516-8522 2007.
5. Hosokawa, M.; Kudo, M.; Maeda, H.; Kohno, H.; Tanaka, T.; Miyashita, K. Fucoxanthin induces apoptosis and enhances the antiproliferative effect of the PPARgamma ligand, troglitazone, on colon cancer cells. Biochim. Biophys. Acta 1675, 113-119 2004.
6. Kotake-Nara, E.; Asai, A.; Nagao, A. Neoxanthin and fucoxanthin induce apoptosis in PC-3 human prostate cancer cells. Cancer Lett. 220, 75-84 2005.
7. Das, S. K.; Ren, R.; Hashimoto, T.; Kanazawa, K. Fucoxanthin induces apoptosis in osteoclast-like cells differentiated from RAW264.7 cells. J. Agric. Food Chem. 58, 6090-6095 2010.
8. Sugawara, T.; Matsubara, K.; Akagi, R.; Mori, M.; Hirata, T. Antiangiogenic activity of brown algae fucoxanthin and its deacetylated product, fucoxanthinol. J. Agric. Food Chem. 54, 9805-9810 2006.
9. Kim, K. N.; Heo, S. J.; Yoon, W. J.; Kang, S. M.; Ahn, G.; Yi, T. H.; Jeon, Y. J. Fucoxanthin inhibits the inflammatory response by suppressing the activation of NFkappaB and MAPKs in lipopolysaccharide-induced RAW 264.7 macrophages. Eur. J. Pharmacol. 649, 369-375 2010.
10. Maeda, H.; Hosokawa, M.; Sashima, T.; Funayama, K.; Miyashita, K. Fucoxanthin from edible seaweed, Undaria pinnatifida, shows antiobesity effect through UCP1 expression in white adipose tissues. Biochem. Biophys. Res. Commun. 332, 392-397 2005.
11. Maeda, H.; Hosokawa, M.; Sashima, T.; Murakami-Funayama, K.; Miyashita, K. Anti-obesity and anti-diabetic effects of fucoxanthin on diet-induced obesity conditions in a murine model. Mol. Med. Report 2, 897-902 2009.
12. Maeda, H.; Hosokawa, M.; Sashima, T.; Miyashita, K. Dietary combination of fucoxanthin and fish oil attenuates the weight gain of white adipose tissue and decreases blood glucose in obese/diabetic KK-Ay mice. J. Agric. Food Chem. 55, 7701-7706 2007.
13. Woo, M. N.; Jeon, S. M.; Shin, Y. C.; Lee, M. K.; Kang, M. A.; Choi, M. S. Anti-obese property of fucoxanthin is partly mediated by altering lipid-regulating enzymes and uncoupling proteins of visceral adipose tissue in mice. Molecular Nutrition & Food Research 53, 1603-1611 2009.
14. Lowell, B. B.; Susulic, V.; Hamann, A.; Lawitts, J. A.; Himms-Hagen, J.; Boyer, B. B.; Kozak, L. P.; Flier, J. S. Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 366, 740-742 1993.
15. Ricquier, D.; Bouillaud, F. Mitochondrial uncoupling proteins: from mitochondria to the regulation of energy balance. J. Physiol. 529, 3-10 2000.
16. Harms, M.; Seale, P. Brown and beige fat: development, function and therapeutic potential. Nat. Med. 19, 1252-1263 2013.
17. Abidov, M.; Ramazanov, Z.; Seifulla, R.; Grachev, S. The effects of Xanthigen in the weight management of obese premenopausal women with non-alcoholic fatty liver disease and normal liver fat. Diabetes Obes. Metab. 12, 72-81 2010.
18. Hosokawa, M.; Miyashita, T.; Nishikawa, S.; Emi, S.; Tsukui, T.; Beppu, F.; Okada, T.; Miyashita, K. Fucoxanthin regulates adipocytokine mRNA expression in white adipose tissue of diabetic/obese KK-Ay mice. Arch. Biochem. Biophys. 504, 17-25 2010.
19. Drevon, C. A. Fatty acids and expression of adipokines. Biochim. Biophys. Acta 1740, 287-292 2005.
20. Asai, A.; Yonekura, L.; Nagao, A. Low bioavailability of dietary epoxyxanthophylls in humans. Br. J. Nutr. 100, 273-277 2008.
21. Maeda, H.; Hosokawa, M.; Sashima, T.; Murakami-Funayama, K.; Miyashita, K. Anti-obesity and anti-diabetic effects of fucoxanthin on diet-induced obesity conditions in a murine model. Mol. Med. Rep. 2, 897-902 2009.
22. Nishikawa, S.; Hosokawa, M.; Miyashita, K. Fucoxanthin promotes translocation and induction of glucose transporter 4 in skeletal muscles of diabetic/obese KKA y mice. Phytomedicine 19, 389-394 2012.
23. Abel, E. D.; Peroni, O.; Kim, J. K.; Kim, Y. B.; Boss, O.; Hadro, E.; Minnemann, T.; Shulman, G. I.; Kahn, B. B. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 409, 729- 733 2001.
24. Kahn, B. B.; Pedersen, O. Suppression of GLUT4 expression in skeletal muscle of rats that are obese from high fat feeding but not from high carbohydrate feeding or genetic obesity. Endocrinology 132, 13-22 1993.
25. Maeda, H.; Hosokawa, M.; Sashima, T.; Takahashi, N.; Kawada, T.; Miyashita, K. Fucoxanthin and its metabolite, fucoxanthinol, suppress adipocyte differentiation in 3T3-L1 cells. Int. J. Mol. Med. 18, 147-152 2006.
26. Yim, M. J.; Hosokawa, M.; Mizushina, Y.; Yoshida, H.; Saito, Y.; Miyashita, K. Suppressive Effects of Amarouciaxanthin A on 3T3-L1 Adipocyte Differentiation through Down-regulation of PPAR gamma and C/EBP alpha mRNA Expression. J. Agric. Food Chem. 59, 1646-1652 2011.
27. Okada, T.; Nakai, M.; Maeda, H.; Hosokawa, M.; Sashima, T.; Miyashita, K. Suppressive efect of neoxanthin on the differentiation of 3T3-L1 adipose cells. J. Oleo Sci. 57, 345-351 2008.
28. Maeda, H.; Saito, S.; Nakamura, N.; Maoka, T. Paprika Pigments Attenuate Obesity-Induced Inflammation in 3T3-L1 Adipocytes. ISRN Inflamm. 2013, 763758 2013.
29. Harris, W. S.; Bulchandani, D. Why do omega-3 fatty acids lower serum triglycerides? Curr. Opin. Lipidol. 17, 387-393 2006.
30. Innis, S. M. Dietary omega 3 fatty acids and the developing brain. Brain Res. 1237, 35-43 2008.
31. Tsukui, T.; Konno, K.; Hosokawa, M.; Maeda, H.; Sashima, T.; Miyashita, K. Fucoxanthin and fucoxanthinol enhance the amount of docosahexaenoic acid in the liver of KKAy obese/diabetic mice. J. Agric. Food Chem. 55, 5025-5029 2007.
32. O’Neill, M. E.; Carroll, Y.; Corridan, B.; Olmedilla, B.; Granado, F.; Blanco, I.; Van D. B. H.; Hininger, I.; Rousell, A. M.; Chopra, M.; Southon, S.; Thurnham, D. I. A European carotenoid database to assess carotenoid intakes and its use in a five-country comparative study. Br. J. Nutr. 85, 499-5072001.
33. Sugawara, T.; Baskaran, V.; Tsuzuki, W.; Nagao, A. Brown algae fucoxanthin is hydrolyzed to fucoxanthinol during absorption by Caco-2 human intestinal cells and mice. J. Nutr. 132, 946-951 2002.
34. Hashimoto, T.; Ozaki, Y.; Taminato, M.; Das, S. K.; Mizuno, M.; Yoshimura, K.; Maoka, T.; Kanazawa, K. The distribution and accumulation of fucoxanthin and its metabolites after oral administration in mice. Br. J. Nutr. 102, 242-248 2009.
35. Maeda, H.; Hosokawa, M.; Sashima, T.; Funayama, K.; Miyashita, K. Effect of medium-chain triacylglycerols on anti-obesity effect of fucoxanthin. J. Oleo Sci. 56, 615-621 2007.
36. Okada, T.; Mizuno, Y.; Sibayama, S.; Hosokawa, M.; Miyashita, K. Antiobesity effects of Undaria lipid capsules prepared with scallop phospholipids. J. Food Sci. 76, H2-H6 2011.
37. Beppu, F.; Niwano, Y.; Tsukui, T.; Hosokawa, M.; Miyashita, K. Single and repeated oral dose toxicity study of fucoxanthin（FX）, a marine carotenoid, in mice. J. Toxicol. Sci. 34, 501-510 2009.
38. Beppu, F.; Niwano, Y.; Sato, E.; Kohno, M.; Tsukui, T.; Hosokawa, M.; Miyashita, K. In vitro and in vivo evaluation of mutagenicity of fucoxanthin（FX）and its metabolite fucoxanthino（l FXOH）. J. Toxicol. Sci. 34, 693-698 2009.